These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 26860671)
1. Prediction of long-term major events soon after a first ST-segment elevation myocardial infarction by cardiovascular magnetic resonance. Bonanad C; Monmeneu JV; Lopez-Lereu MP; Hervas A; de Dios E; Gavara J; Nunez J; Minana G; Husser O; Paya A; Racugno P; García-Blas S; Chorro FJ; Bodi V Eur J Radiol; 2016 Mar; 85(3):585-92. PubMed ID: 26860671 [TBL] [Abstract][Full Text] [Related]
2. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction. Izquierdo M; Ruiz-Granell R; Bonanad C; Chaustre F; Gomez C; Ferrero A; Lopez-Lereu P; Monmeneu JV; Nuñez J; Chorro FJ; Bodi V Circ Cardiovasc Imaging; 2013 Sep; 6(5):755-61. PubMed ID: 23926195 [TBL] [Abstract][Full Text] [Related]
3. Long-term prognostic value of a comprehensive assessment of cardiac magnetic resonance indexes after an ST-segment elevation myocardial infarction. Merlos P; López-Lereu MP; Monmeneu JV; Sanchis J; Núñez J; Bonanad C; Valero E; Miñana G; Chaustre F; Gómez C; Oltra R; Palacios L; Bosch MJ; Navarro V; Llácer A; Chorro FJ; Bodí V Rev Esp Cardiol (Engl Ed); 2013 Aug; 66(8):613-22. PubMed ID: 24776329 [TBL] [Abstract][Full Text] [Related]
4. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy. Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular magnetic resonance-derived intramyocardial hemorrhage after STEMI: Influence on long-term prognosis, adverse left ventricular remodeling and relationship with microvascular obstruction. Husser O; Monmeneu JV; Sanchis J; Nunez J; Lopez-Lereu MP; Bonanad C; Chaustre F; Gomez C; Bosch MJ; Hinarejos R; Chorro FJ; Riegger GA; Llacer A; Bodi V Int J Cardiol; 2013 Sep; 167(5):2047-54. PubMed ID: 22682700 [TBL] [Abstract][Full Text] [Related]
17. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial. Eitel I; Wöhrle J; Suenkel H; Meissner J; Kerber S; Lauer B; Pauschinger M; Birkemeyer R; Axthelm C; Zimmermann R; Neuhaus P; Brosteanu O; de Waha S; Desch S; Gutberlet M; Schuler G; Thiele H J Am Coll Cardiol; 2013 Apr; 61(13):1447-54. PubMed ID: 23466078 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance and relationship of worst lead residual ST segment elevation with myocardial damage assessed by cardiovascular MRI in myocardial infarction. Rommel KP; Baum A; Mende M; Desch S; Gutberlet M; Schuler G; Thiele H; Eitel I Heart; 2014 Aug; 100(16):1257-63. PubMed ID: 25049315 [TBL] [Abstract][Full Text] [Related]
19. High-sensitivity troponin T predicts infarct scar characteristics and adverse left ventricular function by cardiac magnetic resonance imaging early after reperfused acute myocardial infarction. Nguyen TL; Phan JA; Hee L; Moses DA; Otton J; Terreblanche OD; Xiong J; Premawardhana U; Rajaratnam R; Juergens CP; Dimitri HR; French JK; Richards DA; Thomas L Am Heart J; 2015 Oct; 170(4):715-725.e2. PubMed ID: 26386795 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen". Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV; Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]